Skip to main navigation Skip to search Skip to main content

Påvirket leverbiokemi hos børn med reumatologiske sygdomme

Translated title of the contribution: Affected liver biochemistry in children with rheumatic diseases

Abstract

Children with rheumatic diseases often have elevated liver biochemistry. This can be triggered by medical treatment, e.g. methotrexate can induce liver injury ranging from mild to severe. Autoimmune hepatitis and sclerosing cholangitis are also seen in conjunction with rheumatic diseases, and early diagnosis and treatment is crucial to prevent development of cirrhosis and liver transplantation. Macrophage activation syndrome is a rare but important differential diagnosis as it is a potentially fatal complication to systemic rheumatic diseases, causing liver dysfunction and multi-organ failure.

Translated title of the contributionAffected liver biochemistry in children with rheumatic diseases
Original languageDanish
JournalUgeskrift for Laeger
Volume180
Issue number22
Pages (from-to)V06170472
ISSN0041-5782
Publication statusPublished - 28 May 2018

Fingerprint

Dive into the research topics of 'Affected liver biochemistry in children with rheumatic diseases'. Together they form a unique fingerprint.

Cite this